These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6577010)

  • 1. Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80.
    Salzer-Kuntschik M; Delling G; Beron G; Sigmund R
    J Cancer Res Clin Oncol; 1983; 106 Suppl():21-4. PubMed ID: 6577010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological changes in osteosarcoma after chemotherapy--COSS 80.
    Delling G; Krumme H; Salzer-Kuntschik M
    J Cancer Res Clin Oncol; 1983; 106 Suppl():32-7. PubMed ID: 6577012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study.
    Winkler K; Beron G; Kotz R; Salzer-Kuntschik M; Beck J; Beck W; Brandeis W; Ebell W; Erttmann R; Göbel U; Havers W; Henze G; Hinderfield L; Höcker P; Jobke A; Jürgens H; Kabisch H; Landbeck G; Preusser P; Prindull G; Ramach W; Ritter J; Sekera J; Treuner J; Wüst G
    J Cancer Res Clin Oncol; 1983; 106 Suppl():1-7. PubMed ID: 6193123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of the degree of morphological regression following chemotherapy in malignant bone tumors].
    Salzer-Kuntschik M; Brand G; Delling G
    Pathologe; 1983 May; 4(3):135-41. PubMed ID: 6576329
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy-induced changes in osteosarcoma after neoadjuvant chemotherapy (COSS 86 Therapy Study). Correlation between morphologic findings and clinical follow-up].
    Werner M; Fuchs N; Salzer-Kuntschik M; Winkler K; Delling G
    Pathologe; 1996 Jan; 17(1):35-43. PubMed ID: 8685094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
    Schulte M; Brecht-Krauss D; Werner M; Hartwig E; Sarkar MR; Keppler P; Kotzerke J; Guhlmann A; Delling G; Reske SN
    J Nucl Med; 1999 Oct; 40(10):1637-43. PubMed ID: 10520703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteogenic progenitor cell potency after high-dose chemotherapy (COSS-96).
    Jäger M; Schultheis A; Westhoff B; Krauspe R
    Anticancer Res; 2005; 25(2A):947-54. PubMed ID: 15868932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
    Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
    Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytostatic effects in osteosarcomas as detected by flow cytometric DNA analysis after preoperative chemotherapy according to the COSS 80/82 protocol.
    Bösing T; Roessner A; Hiddemann W; Mellin W; Grundmann E
    J Cancer Res Clin Oncol; 1987; 113(4):369-75. PubMed ID: 3474234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant chemotherapy of malignant bone tumors].
    Wilmanns W; Sauer H; Schalhorn A
    Langenbecks Arch Chir; 1982; 358():393-8. PubMed ID: 6963363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
    Eselgrim M; Grunert H; Kühne T; Zoubek A; Kevric M; Bürger H; Jürgens H; Mayer-Steinacker R; Gosheger G; Bielack SS
    Pediatr Blood Cancer; 2006 Jul; 47(1):42-50. PubMed ID: 16206218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it ethical not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma?
    Lange B; Levine AS
    Cancer Treat Rep; 1982 Sep; 66(9):1699-704. PubMed ID: 6749284
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of polychemotherapy in the prevention of metastases of osteogenic sarcoma to the lungs].
    Knysh IT
    Ortop Travmatol Protez; 1980 Dec; (12):1-3. PubMed ID: 6938897
    [No Abstract]   [Full Text] [Related]  

  • 14. 18F-FDG PET SUVmax correlates with osteosarcoma histologic response to neoadjuvant chemotherapy: preclinical evaluation in an orthotopic rat model.
    Dutour A; Decouvelaere AV; Monteil J; Duclos ME; Roualdes O; Rousseau R; Marec-Bérard P
    J Nucl Med; 2009 Sep; 50(9):1533-40. PubMed ID: 19690032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment in the COSS 80 study.
    Kotz R; Becker W; Immenkamp M
    J Cancer Res Clin Oncol; 1983; 106 Suppl():8-10. PubMed ID: 6577018
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicity associated with combination chemotherapy for osteosarcoma: a report of the cooperative osteosarcoma study (COSS 80).
    Jürgens H; Beron G; Winkler K
    J Cancer Res Clin Oncol; 1983; 106 Suppl():14-8. PubMed ID: 6350313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.
    Winkler K; Beron G; Delling G; Heise U; Kabisch H; Purfürst C; Berger J; Ritter J; Jürgens H; Gerein V
    J Clin Oncol; 1988 Feb; 6(2):329-37. PubMed ID: 2448428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary osteosarcoma of the head and neck in pediatric patients: a clinicopathologic study of 22 cases with a review of the literature.
    Gadwal SR; Gannon FH; Fanburg-Smith JC; Becoskie EM; Thompson LD
    Cancer; 2001 Feb; 91(3):598-605. PubMed ID: 11169944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinico-radiological assessment of chemotherapy for osteosarcoma received prior to surgery].
    Krzhivitskiĭ PI; Vesnin AG; Kolygin BA; Turkevich EA; Zasul'skiĭ FIu
    Vopr Onkol; 2004; 50(4):430-4. PubMed ID: 15605766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.